114 related articles for article (PubMed ID: 12214337)
1. [Treatment of non-alcoholic steatohepatitis (NASH). A comparative study of ursodeoxycholic acid and alpha-tocopherol. A preliminary report].
Bernal-Reyes R; Escudero RB
Rev Gastroenterol Mex; 2002; 67(2):70-5. PubMed ID: 12214337
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study.
Georgescu EF; Georgescu M
J Gastrointestin Liver Dis; 2007 Mar; 16(1):39-46. PubMed ID: 17410287
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.
Laurin J; Lindor KD; Crippin JS; Gossard A; Gores GJ; Ludwig J; Rakela J; McGill DB
Hepatology; 1996 Jun; 23(6):1464-7. PubMed ID: 8675165
[TBL] [Abstract][Full Text] [Related]
4. Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment.
Ersöz G; Günşar F; Karasu Z; Akay S; Batur Y; Akarca US
Turk J Gastroenterol; 2005 Sep; 16(3):124-8. PubMed ID: 16245220
[TBL] [Abstract][Full Text] [Related]
5. Treatment for NASH: the value of histology.
Elitsur Y; Lawrence Z; Wang R; Durst PR
Am J Gastroenterol; 2005 Jan; 100(1):250-1. PubMed ID: 15654810
[No Abstract] [Full Text] [Related]
6. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis.
Dufour JF; Oneta CM; Gonvers JJ; Bihl F; Cerny A; Cereda JM; Zala JF; Helbling B; Steuerwald M; Zimmermann A;
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1537-43. PubMed ID: 17162245
[TBL] [Abstract][Full Text] [Related]
7. The role of ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review.
Xiang Z; Chen YP; Ma KF; Ye YF; Zheng L; Yang YD; Li YM; Jin X
BMC Gastroenterol; 2013 Sep; 13():140. PubMed ID: 24053454
[TBL] [Abstract][Full Text] [Related]
8. Treatment of NASH with ursodeoxycholic acid: cons.
Liechti F; Dufour JF
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S46-52. PubMed ID: 23141894
[TBL] [Abstract][Full Text] [Related]
9. Treatment of NASH with ursodeoxycholic acid: pro.
Ratziu V
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S41-5. PubMed ID: 23141893
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.
Kiyici M; Gulten M; Gurel S; Nak SG; Dolar E; Savci G; Adim SB; Yerci O; Memik F
Can J Gastroenterol; 2003 Dec; 17(12):713-8. PubMed ID: 14679419
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial comparing the effects of Vitamin E, Ursodeoxycholic acid and Pentoxifylline on Egyptian non-alcoholic steatohepatitis patients.
Fouda A; Abdelaziz AE; Hussien M; Ali AA; Abdelkawy KS; Elbarbry F
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7449-7459. PubMed ID: 34919247
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial.
Lindor KD; Kowdley KV; Heathcote EJ; Harrison ME; Jorgensen R; Angulo P; Lymp JF; Burgart L; Colin P
Hepatology; 2004 Mar; 39(3):770-8. PubMed ID: 14999696
[TBL] [Abstract][Full Text] [Related]
13. Bezafibrate treatment of primary biliary cirrhosis following incomplete response to ursodeoxycholic acid.
Hazzan R; Tur-Kaspa R
J Clin Gastroenterol; 2010; 44(5):371-3. PubMed ID: 19881358
[TBL] [Abstract][Full Text] [Related]
14. Effects of ursodeoxycholic acid therapy on carotid intima media thickness, apolipoprotein A1, apolipoprotein B, and apolipoprotein B/A1 ratio in nonalcoholic steatohepatitis.
Ozel Coskun BD; Yucesoy M; Gursoy S; Baskol M; Yurci A; Yagbasan A; Doğan S; Baskol G
Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):142-9. PubMed ID: 25533429
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis.
Ratziu V; de Ledinghen V; Oberti F; Mathurin P; Wartelle-Bladou C; Renou C; Sogni P; Maynard M; Larrey D; Serfaty L; Bonnefont-Rousselot D; Bastard JP; Rivière M; Spénard J;
J Hepatol; 2011 May; 54(5):1011-9. PubMed ID: 21145828
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of primary biliary cirrhosis with ursodeoxycholic acid].
Nikolovska D; Vasilev P; Mikhova A
Vutr Boles; 2000; 32(1):25-7. PubMed ID: 11195193
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of ursodeoxycholic acid (UDCA) in the treatment of chronic alcoholic hepatitis].
Preobrazhenskiĭ VN; Taianovskiĭ VIu
Klin Med (Mosk); 1998; 76(5):26-8. PubMed ID: 9644931
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic steatohepatitis.
Kumar KS; Malet PF
Mayo Clin Proc; 2000 Jul; 75(7):733-9. PubMed ID: 10907390
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.
Talwalkar JA; Angulo P; Keach JC; Petz JL; Jorgensen RA; Lindor KD
J Clin Gastroenterol; 2005 Feb; 39(2):168-71. PubMed ID: 15681915
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid and artesunate in the treatment of severe falciparum malaria patients with jaundice.
Treeprasertsuk S; Silachamroon U; Krudsood S; Huntrup A; Suwannakudt P; Vannaphan S; Wilairatana P
J Gastroenterol Hepatol; 2010 Feb; 25(2):362-8. PubMed ID: 19817958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
